{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:51:11Z","timestamp":1789678271010,"version":"4.0.1"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Albuminuria is a marker of inflammation and an independent predictor of cardiovascular morbidity and mortality. The current study evaluated whether eicosapentaenoic acid (\n              <jats:styled-content style=\"fixed-case\">EPA<\/jats:styled-content>\n              ) and docosahexaenoic acid (\n              <jats:styled-content style=\"fixed-case\">DHA<\/jats:styled-content>\n              ) supplementation attenuates progression of albuminuria in subjects with coronary artery disease.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Two\u2010hundred sixty\u2010two subjects with stable coronary artery disease were randomized to either Lovaza (1.86\u00a0g of EPA and 1.5\u00a0g of DHA daily) or no Lovaza (control) for 1\u00a0year. Percent change in urine albumin\u2010to\u2010creatinine ratio (\n              <jats:styled-content style=\"fixed-case\">ACR<\/jats:styled-content>\n              ) was compared. Mean (\n              <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>\n              ) age was 63.3 (7.6) years; 17% were women and 30% had type 2 diabetes mellitus. In nondiabetic subjects, no change in urine\n              <jats:styled-content style=\"fixed-case\">ACR<\/jats:styled-content>\n              occurred in either the Lovaza or control groups. In contrast,\n              <jats:styled-content style=\"fixed-case\">ACR<\/jats:styled-content>\n              increased 72.3% (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001) in diabetic subjects not receiving Lovaza, whereas those receiving Lovaza had no change. In diabetic subjects on an angiotensin\u2010converting enzyme\u2010inhibitor or angiotensin\u2010receptor blocker, those receiving Lovaza had no change in urine\n              <jats:styled-content style=\"fixed-case\">ACR<\/jats:styled-content>\n              , whereas those not receiving Lovaza had a 64.2% increase (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001). Change in\n              <jats:styled-content style=\"fixed-case\">ACR<\/jats:styled-content>\n              was directly correlated with change in systolic blood pressure (\n              <jats:italic>r<\/jats:italic>\n              =0.394,\n              <jats:italic>P<\/jats:italic>\n              =0.01).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">EPA<\/jats:styled-content>\n              and\n              <jats:styled-content style=\"fixed-case\">DHA<\/jats:styled-content>\n              supplementation attenuated progression of albuminuria in subjects with type 2 diabetes mellitus and coronary artery disease, most of whom were on an angiotensin\u2010converting enzyme\u2010inhibitor or angiotensin\u2010receptor blocker. Thus,\n              <jats:styled-content style=\"fixed-case\">EPA<\/jats:styled-content>\n              and\n              <jats:styled-content style=\"fixed-case\">DHA<\/jats:styled-content>\n              supplementation should be considered as additional therapy to an angiotensin\u2010converting enzyme\u2010inhibitor or angiotensin\u2010receptor blocker in subjects with type 2 diabetes mellitus and coronary artery disease.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Clinical Trial Registration<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">URL<\/jats:styled-content>\n              :\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">http:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n              . Unique identifier:\n              <jats:styled-content style=\"fixed-case\">NCT<\/jats:styled-content>\n              01624727.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.116.004740","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:10:18Z","timestamp":1500077418000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease"],"prefix":"10.1161","volume":"6","author":[{"given":"Tarec K.","family":"Elajami","sequence":"first","affiliation":[{"name":"Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhamied","family":"Alfaddagh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharshan","family":"Lakshminarayan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Soliman","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Chandnani","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine K.","family":"Welty","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-015-1121-y"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.07.005"},{"key":"e_1_3_4_4_2","first-page":"247","article-title":"The concomitants of raised blood sugar: studies in newly\u2010detected hyperglycemics II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels","volume":"118","author":"Keen H","year":"1969","unstructured":"Keen H, Chlouverakis C, Fuller J, Jarrett RJ. The concomitants of raised blood sugar: studies in newly\u2010detected hyperglycemics II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guys Hosp Rep. 1969;118:247\u2013254.","journal-title":"Guys Hosp Rep"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91002-2"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2001.00833.x"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.31388"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.3.617"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816090-00014"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.128"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7060.779"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.4.421"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440340025002"},{"key":"e_1_3_4_14_2","first-page":"530","article-title":"Microalbuminuria as predictor of vascular disease in non\u2010diabetic subjects. Islington Diabetes Survey","volume":"2","author":"Yudkin JS","year":"1998","unstructured":"Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non\u2010diabetic subjects. Islington Diabetes Survey. Lancet. 1998;2:530\u2013533.","journal-title":"Lancet"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.8.1992"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000031732.78052.81"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh008"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.538132"},{"key":"e_1_3_4_19_2","first-page":"973","article-title":"Correlation between microalbuminuria and cardiovascular events","volume":"6","author":"Wang Y","year":"2013","unstructured":"Wang Y, Yuan A, Yu C. Correlation between microalbuminuria and cardiovascular events. Int J Clin Exp Med. 2013;6:973\u2013978.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00742-X"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003245"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20792"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005121288"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.08.041"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/362801a0"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht132"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00285287"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000154082.72286.2a"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200409000-00026"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-S012"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-012-0279-3"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2008.26867"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(95)01056-J"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/1056-8727(95)00081-X"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2005.08.007"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1940"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004060447"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2015.06.017"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1987.tb00906.x"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(00)00414-9"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00092.x"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.04.010"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008030292"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.106567"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.4.572"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.053777"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.081471"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00805-3"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010091001"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09805.x"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.156"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2009.28374"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02180311"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.57.s75.3.x"},{"key":"e_1_3_4_57_2","first-page":"S36","article-title":"Lipids in progression of renal disease","volume":"62","author":"Oda H","year":"1997","unstructured":"Oda H, Keane WF. Lipids in progression of renal disease. Kidney Int Suppl. 1997;62:S36\u2013S38.","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.7.1942"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-5-663"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.116.004740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:30:19Z","timestamp":1715596219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.116.004740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1161\/JAHA.116.004740"],"URL":"https:\/\/doi.org\/10.1161\/jaha.116.004740","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"2016-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e004740"}}